

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.


Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal


UK earnings, trading statements calendar - next 7 days


Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim


(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelhe...


LONDON MARKET PRE-OPEN: Returns in store for BP shareholders


By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines ...


Sanofi to terminate haemophilia development pact with Oxford Biomedica